ArticleFrontiers in immunology2023

Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice.

Dawei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.